Department of Anorectal, Kunming Municipal Hospital of Traditional Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Front Immunol. 2024 Aug 23;15:1446532. doi: 10.3389/fimmu.2024.1446532. eCollection 2024.
Despite the increasing number of studies on nanomedicine-based cancer immunotherapy, the overall research trends in this field remain inadequately characterized. This study aims to evaluate the research trends and hotspots in nanomedicine-based cancer immunotherapy through a bibliometric analysis. As of March 31, 2024, relevant publications were retrieved from the Web of Science Core Collection. Analytical tools including VOSviewer, CiteSpace, and an online bibliometric analysis platform were employed. A total of 5,180 publications were analyzed. The study reveals geographical disparities in research output, with China and the United States being the leading contributors. Institutionally, the Chinese Academy of Sciences, University of Chinese Academy of Sciences, and Sichuan University are prominent contributors. Authorship analysis identifies key researchers, with Liu Zhuang being the most prolific author. "ACS Nano" and the "Journal of Controlled Release and Biomaterials" are identified as the leading journals in the field. Frequently occurring keywords include "cancer immunotherapy" and "drug delivery." Emerging frontiers in the field, such as "mRNA vaccine," "sonodynamic therapy," "oral squamous cell carcinoma," "STING pathway,"and "cGAS-STING pathway," are experiencing rapid growth. This study aims to provide new insights to advance scientific research and clinical applications in nanomedicine-based cancer immunotherapy.
尽管基于纳米医学的癌症免疫治疗的研究越来越多,但该领域的整体研究趋势仍未得到充分描述。本研究旨在通过文献计量分析评估基于纳米医学的癌症免疫治疗的研究趋势和热点。截至 2024 年 3 月 31 日,从 Web of Science 核心合集检索到相关出版物。使用了 VOSviewer、CiteSpace 和在线文献计量分析平台等分析工具。共分析了 5180 篇出版物。研究揭示了研究产出的地理差异,中国和美国是主要贡献者。在机构层面上,中国科学院、中国科学院大学和四川大学是突出的贡献者。作者分析确定了关键研究人员,其中刘庄是最有成果的作者。“ACS Nano”和“控释杂志和生物材料”被确定为该领域的领先期刊。经常出现的关键词包括“癌症免疫治疗”和“药物输送”。该领域的新兴前沿,如“mRNA 疫苗”、“声动力学疗法”、“口腔鳞状细胞癌”、“STING 途径”和“cGAS-STING 途径”,正在迅速发展。本研究旨在为推进基于纳米医学的癌症免疫治疗的科学研究和临床应用提供新的见解。
J Control Release. 2022-12
Front Immunol. 2024
Drug Deliv Transl Res. 2024-6
Front Immunol. 2023
Signal Transduct Target Ther. 2024-2-5
Int J Oral Sci. 2023-9-22
Cancer Cell. 2023-4-10